Paper41534849
Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review.
Liu P and 8 others. J Enzyme Inhib Med Chem, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review. Papers, record 41534849. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41534849
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mitogen-activated protein kinase kinase 4 (MKK4) as a promising therapeutic target in liver diseases: a review.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Kinase Inhibitors | Major topic |
| Liver Diseases | Major topic |
| MAP Kinase Kinase 4 | Major topic |
| Humans | |
| Structure-Activity Relationship | |
| Animals | |
| Molecular Structure |
Source PubMed
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33794385 | Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33794385 | PubMed |
| 2 | 26900761 | Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). | J Nat Prod | 2016 | https://conductscience.org/library/papers/26900761 | PubMed |
| 3 | 20732303 | Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state. | Biochem Biophys Res Commun | 2010 | https://conductscience.org/library/papers/20732303 | PubMed |
| 4 | 34971873 | Quercetin derivatives: Drug design, development, and biological activities, a review. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/34971873 | PubMed |
| 5 | 33510482 | Natural products in drug discovery: advances and opportunities. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33510482 | PubMed |
| 6 | 38906596 | MKK4 inhibitor: the hope for liver failure prevention and potential small liver graft transplantation. | Chin J Nat Med | 2024 | https://conductscience.org/library/papers/38906596 | PubMed |
| 7 | 36164393 | MKK4 Knockdown Plays a Protective Role in Hemorrhagic Shock-Induced Liver Injury through the JNK Pathway. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/36164393 | PubMed |
| 8 | 35868124 | Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/35868124 | PubMed |
| 9 | 32906177 | Hemostasis and Liver Regeneration. | Semin Thromb Hemost | 2020 | https://conductscience.org/library/papers/32906177 | PubMed |
| 10 | 40643363 | Discovery of the First Highly Selective 1,4-dihydropyrido[3,4-b]pyrazin-3(2H)-one MKK4 Inhibitor. | J Med Chem | 2025 | https://conductscience.org/library/papers/40643363 | PubMed |
| 11 | 21844199 | c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21844199 | PubMed |
| 12 | 30982749 | Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome. | Cell Chem Biol | 2019 | https://conductscience.org/library/papers/30982749 | PubMed |
| 13 | 39218152 | The Progress and Promise of Lineage Reprogramming Strategies for Liver Regeneration. | Cell Mol Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/39218152 | PubMed |
| 14 | 21084726 | MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story's getting old. | Aging (Albany NY) | 2010 | https://conductscience.org/library/papers/21084726 | PubMed |
| 15 | 32969030 | Hepatocyte Mitogen-Activated Protein Kinase Kinase 7 Contributes to Restoration of the Liver Parenchyma Following Injury in Mice. | Hepatology | 2021 | https://conductscience.org/library/papers/32969030 | PubMed |
| 16 | 9096336 | Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9096336 | PubMed |
| 17 | 30707493 | Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors. | ChemMedChem | 2019 | https://conductscience.org/library/papers/30707493 | PubMed |
| 18 | 33101607 | The autoinhibited state of MKK4: Phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations. | Comput Struct Biotechnol J | 2020 | https://conductscience.org/library/papers/33101607 | PubMed |
| 19 | 26867034 | JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells. | Stem Cells | 2016 | https://conductscience.org/library/papers/26867034 | PubMed |
| 20 | 9876179 | Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4. | Development | 1999 | https://conductscience.org/library/papers/9876179 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41534849
GET https://conductscience.org/api/papers/v1/41534849/references?page=2